Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | STAT3 | P40763 | 1/20 | 0.31 |
| ▸ | PPOX | P50336 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6222332 | 0.77 | ALDH1A1 (0.43) | ALDH1A1HTTGAAHPGDSMN1; SMN2 | |
| SCHEMBL44008 | 0.72 | POLB (0.41) | ALDH1A1HTTGAAHPGDSMN1; SMN2 | |
| SCHEMBL12332676 | 0.72 | ALDH1A1 (0.41) | ALDH1A1HTTGAAHPGDSMN1; SMN2 | |
| SCHEMBL13239527 | 0.72 | ALDH1A1 (0.41) | ALDH1A1HTTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL18072219 | 0.72 | POLB (0.41) | ALDH1A1HTTGAAHPGDSMN1; SMN2 | |
| SCHEMBL6731258 | 0.72 | ALDH1A1 (0.41) | ALDH1A1HTTGAAHPGDSMN1; SMN2 | |
| SCHEMBL10715568 | 0.72 | ALDH1A1 (0.45) | ALDH1A1HTTGAAHPGDSMN1; SMN2 | |
| SCHEMBL761658 | 0.72 | ALDH1A1 (0.41) | ALDH1A1HTTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL13206576 | 0.72 | ALDH1A1 (0.41) | ALDH1A1HTTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL486926 | 0.72 | POLB (0.41) | ALDH1A1HTTGAAHPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210321608-A1 | PYRETHROID FORMULATIONS | SILICON VALLEY BANK (CA) | 2021-10-21 | — | — | US | disclosed |
| EP-2747556-B1 | PYRETHROID FORMULATIONS | VIVE CROP PROT INC (CA) | 2021-08-11 | — | — | EP | disclosed |
| US-10966422-B2 | Pyrethroid formulations | VIVE CROP PROTECTION INC. (CA) | 2021-04-06 | — | — | US | disclosed |
| EP-2048953-B1 | INSECTICIDAL COMPOSITION | MCLAUGHLIN GORMLEY KING CO (US) | 2020-11-18 | — | — | EP | disclosed |
| US-20200138018-A1 | PYRETHROID FORMULATIONS | SILICON VALLEY BANK (CA) | 2020-05-07 | — | — | US | disclosed |
| US-10455830-B2 | Pyrethroid formulations | VIVE CROP PROTECTION INC. (CA) | 2019-10-29 | — | — | US | disclosed |
| US-20170360032-A1 | PYRETHROID FORMULATIONS | SILICON VALLEY BANK (CA) | 2017-12-21 | — | — | US | disclosed |
| US-9686979-B2 | Pyrethroid formulations | VIVE CROP PROTECTION INC. (CA) | 2017-06-27 | — | — | US | disclosed |
| US-20140187424-A1 | PYRETHROID FORMULATIONS | VIVE CROP PROTECTION INC. (CA) | 2014-07-03 | — | — | US | disclosed |
| EP-2747556-A2 | PYRETHROID FORMULATIONS | Vive Crop Protection Inc. (CA) | 2014-07-02 | — | — | EP | disclosed |
| US-20040209960-A1 | Methods of treating lower urinary tract disorders using sodium channell modulators | DYNOGEN PHARMACEUTICALS, INC. | 2004-10-21 | — | — | US | disclosed |
| WO-2004066990-A2 | METHODS OF TREATING LOWER URINARY TRACT DISORDERS USING SODIUM CHANNEL MODULATORS | DYNOGEN PHARMACEUTICALS, INC. (US) | 2004-08-12 | — | — | WO | disclosed |
| WO-2004066987-A2 | USE OF SODIUM CHANNEL MODULATORS FOR TREATING GASTROINTESTINAL TRACT DISORDERS | DYNOGEN PHARMACEUTICALS, INC. (US) | 2004-08-12 | — | — | WO | disclosed |
| US-5506269-A | Parasiticide employing pyrethroid type compounds | MITSUI TOATSU CHEMICALS, INC. (JP) | 1996-04-09 | — | — | US | disclosed |
| EP-0665011-A1 | Parasiticide against endoparasites comprising a pyrethroid type compound | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1995-08-02 | — | — | EP | disclosed |
| US-5128329-A | Fenitrothion, sorbitan monooleate, xanthan gum | SUMITOMO CORPORATION (JP) | 1992-07-07 | — | — | US | disclosed |
| EP-0131762-A1 | Agricultural chemical preparation in the form of aqueous suspension | Sumitomo Corporation (JP) | 1985-01-23 | — | — | EP | disclosed |
| US-4000266-A | (1-CYCLOHEXENE-1,2-DICARBOXAMIDO)METHYL CHRYSANTHEMUMATE, (5-BENZYL-3-FURYL)METHYL CHRYSANTHEMUMATE | FMC CORPORATION (US) | 1976-12-28 | — | — | US | disclosed |
| US-4000266-A | (1-CYCLOHEXENE-1,2-DICARBOXAMIDO)METHYL CHRYSANTHEMUMATE, (5-BENZYL-3-FURYL)METHYL CHRYSANTHEMUMATE | FMC CORPORATION (US) | 1976-12-28 | — | — | US | disclosed |
| US-3944666-A | Insecticidal compositions and methods of combatting insects using 3-phenoxybenzyl 2,2-dimethyl-3-(2,2-dichlorovinyl)-cyclopropanecarboxylate insecticide with a synergistic compound of mono (alkyl and alkenyl)mono omega-alkynyl arylphosphonates | FMC CORPORATION (US) | 1976-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140187424-A1 | PYRETHROID FORMULATIONS | DDT, PCNP, MGST3 | ALDH1A1 2794/4885HTT 2171/4885GAA 2021/4885 |
| US-20170360032-A1 | PYRETHROID FORMULATIONS | DDT, PCNP, MGST3 | ALDH1A1 2794/4885HTT 2171/4885GAA 2021/4885 |
| US-20210321608-A1 | PYRETHROID FORMULATIONS | DDT, PCNP, MGST3 | ALDH1A1 2794/4885HTT 2171/4885GAA 2021/4885 |
| US-10966422-B2 | Pyrethroid formulations | DDT, PCNP, MGST3 | ALDH1A1 2794/4885HTT 2171/4885GAA 2021/4885 |
| US-20200138018-A1 | PYRETHROID FORMULATIONS | DDT, PCNP, MGST3 | ALDH1A1 2794/4885HTT 2171/4885GAA 2021/4885 |
| US-20040209960-A1 | Methods of treating lower urinary tract disorders using sodium channell modulators | CACNA1G, CACNA1D, CACNA1B | ALDH1A1 1586/4885HTT 1018/4885GAA 1563/4885 |
| US-10455830-B2 | Pyrethroid formulations | DDT, PCNP, MGST3 | ALDH1A1 2794/4885HTT 2171/4885GAA 2021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.